Significant metabolic alterations in non-small cell lung cancer patients by epidermal growth factor receptor-targeted therapy and PD-1/PD-L1 immunotherapy

Background: Cancer-related deaths are primarily attributable to lung cancer, of which non-small cell lung cancer (NSCLC) is the most common type. Molecular targeting therapy and antitumor immunotherapy have both made great strides in the treatment of NSCLC, but their underlying mechanisms remain unc...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Chen, Wu, Dan, Gan, Lingling, Wang, Jun, Yang, Wenyu, Xu, Bei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403486/
https://www.ncbi.nlm.nih.gov/pubmed/36034789
http://dx.doi.org/10.3389/fphar.2022.949745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403486/
https://www.ncbi.nlm.nih.gov/pubmed/36034789
http://dx.doi.org/10.3389/fphar.2022.949745

Ejemplares similares